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Abstract
Elucidating the genetic determinants of radiation response is crucial to optimizing and indi-
vidualizing radiotherapy for cancer patients. In order to identify genes that are involved in
enhanced sensitivity or resistance to radiation, a library of stable mutant murine embryonic
stem cells (ESCs), each with a defined mutation, was screened for cell viability and gene ex-
pression in response to radiation exposure. We focused on a cancer-relevant subset of
over 500 mutant ESC lines. We identified 13 genes; 7 genes that have been previously im-
plicated in radiation response and 6 other genes that have never been implicated in radia-
tion response. After screening, proteomic analysis showed enrichment for genes involved
in cellular component disassembly (e.g. Dstn and Pex14) and regulation of growth (e.g.
Adnp2, Epc1, and Ing4). Overall, the best targets with the highest potential for sensitizing
cancer cells to radiation were Dstn andMap2k6, and the best targets for enhancing resis-
tance to radiation were Iqgap and Vcan. Hence, we provide compelling evidence that
screening mutant ESCs is a powerful approach to identify genes that alter radiation re-
sponse. Ultimately, this knowledge can be used to define genetic variants or therapeutic tar-
gets that will enhance clinical therapy.
Introduction
Radiation therapy is one of the primary treatment modalities for cancer. For example, up to
95% of breast cancer patients receive radiotherapy [1]. Enhanced efficacy could reduce side ef-
fects and improve outcomes. An understanding of the individual genes that make some people
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more sensitive or resistant to radiation could be used to tailor the dose or other therapeutics to
the individual being treated. Several factors influence the efficacy of radiation therapy. In gen-
eral, DNA repair systems and cell cycle checkpoints work together to maintain the genomic in-
tegrity of cells damaged by ionizing radiation. Much research has already been done on the
molecular mechanisms that control the cellular response to radiation; however, the genetic
basis of individual radiation response is not well understood. In fact, individual response to ra-
diation is highly variable and can be considerably different depending on the dose range and
rate [2]. There is evidence of linkage to specific chromosomal regions [3]; however, candidate
gene studies have typically failed to discover variants associated with radiosensitivity. Further,
while several genome wide association studies have been performed in humans and flies, the
hits contribute only modest effect sizes [4].
A second factor complicating radiation therapy is the presence of radiation resistant cancer
stem cells (CSCs). CSCs are a small, self-renewing sub-population of cells found in many cancer
types. CSCs drive tumor development and metastasis, and most treatments including radiation
therapy do not target CSCs. As it is these cells that are resistant to radiation, they contribute to
treatment failure and relapse [5–8]. Therefore, specifically targeting CSCs would improve out-
come for many patients.
Embryonic stem cells (ESCs) provide good models for CSCs. They share the same active
transcription factors that regulate self-renewal and differentiation leading to tumor initiation
and neoplastic proliferation [9–11]. One of the first studies to document this showed that
genes associated with ESC identity were also expressed in poorly differentiated aggressive
human tumors including breast, glioblastomas and bladder carcinomas [9]. Further works es-
tablished the link between genes important for development and cancer by focusing on the di-
verse human epithelial cancers and c-Myc expression [12]. The well-defined pluripotency
markers of ESCs such as Oct4, Sox2, Klf4, Nanog, and c-Myc have been shown to be commonly
up-regulated in cancers and associated with tumor progression and increased risk of poor
prognosis [13]. Further, like CSCs, ESCs are radiation resistant as they both employ the same
mechanisms of self-protection including increased expression of DNA-repair pathways and re-
sistance to reactive oxygen and nitrogen species [5,14].
Studying ESCs has several practical advantages over utilizing CSCs. ESCs are more readily
isolated and have unlimited capacity for expansion, making them relatively easy to maintain in
culture. In contrast, CSCs exist as a small population within a patient’s tumor, replicate infre-
quently, and are thus unable to be isolated and expanded to obtain the required numbers for
study. ESCs have a stable genome and normal karyotype while cancer cell lines are constantly
acquiring new genetic mutations. Also, ESCs are pluripotent and can be directed to differenti-
ate into specific cell types in vitro. In contrast, the only known method for the full differentia-
tion of CSCs without recurrence of carcinogenesis is their injection into an embryonic
environment [15–18].
We utilized a novel screening approach in order to identify genetic factors involved in sensi-
tivity and resistance to radiation in stem cells. As mutant ESC lines for virtually every protein-
coding gene in the mouse genome are readily accessible [19–22], we selected and screened a
subset of over 500 cancer candidate genes for radiation response. We screened for changes in
both cell viability and gene expression. In order to be able to cross reference our two screening
assays directly with one another on a gene-by-gene basis, we performed assays simultaneously
for individual mutant clones 24 hours after irradiation. A similar screen for altered gene ex-
pression of gene traps in response to radiation identified 3 loci [23], but while it reports screen-
ing 6669 clones, there was no characterization of the diversity of their library, as they were not
defined mutations from the outset. Hence, the fact that our library has pre-defined mutations
is an asset. Two different radiation absorbed doses were screened; 0.5-Gy and 4-Gy. As these
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doses are not expected to cause cell lethality, especially in stem cells, we chose to evaluate via-
bility and gene expression. We validated 13 clones as having altered phenotypes. Six of these
genes have never been implicated in radiation response. Seven of the validated genes are al-
ready implicated in the literature as having a radiation response, thus confirming the validity
of the screen. In particular Klf8, Dstn andMap2k6merit additional follow-up as down regulat-
ing these pathways enhances radiation response. Additionally, Iqgap and Vcan should be inhib-
ited to enhance resistance or treat exposure in personnel exposed occupationally to radiation.
Materials and Methods
ES cell library and clone selection
Gene trap technology generates random loss-of-function mutations through insertional muta-
genesis. High throughput gene trapping is a powerful technique that simultaneously integrates
gene identification with expression and function into a single process [24]. We utilized ESC
clones created by large-scale gene trapping in C57BL/6N mouse ESC [20]. Hansen et al. used
high-throughput gene trapping with retroviral vectors in mouse C57BL/6N ESCs to generate a
library containing 481,152 mutated ESC clones. The gene trapping construct contained a splice
acceptor, a selectable marker gene (frequently a fusion of β-galactosidase and neomycin), and a
polyadenylation signal that is placed within a retroviral genome such that it can be packaged
into retroviral particles and used to infect cells. Using an automated, genomic-based inverse-
PCR (IPCR) sequencing and annotation protocol they have produced a total of 532,829 inser-
tion site sequence tags (ISTs) derived from 352,402 (or 73%) of these clones. When insertions
occur within transcriptionally active regions, the marker gene is expressed and translated, al-
lowing selection of mutant clones. Gene disruption is accomplished most often through the
capture of endogenous gene transcription by the splice acceptor element within the trapping
construct, or alternatively, by direct gene disruption as a result of insertion within an exon. Mu-
tations have been identified in more than 10,000 unique genes and show a bias toward the first
intron. The trapped ES cell lines, which can be requested from the Texas A&M Institute for Ge-
nomic Medicine, are readily available to the scientific community. Since many gene-trapping
vectors contained β-geo, this allowed us to track the endogenous expression of the trapped
gene through β-gal.
We focused our studies on a subset of ESC clones from our library and chose to evaluate can-
cer candidate genes utilizing the same gene list as The Cancer Genome Atlas (TCGA). As our
gene trap library frequently contains multiple mutant clones for any given gene, all the clones
were ranked based on relevant characteristics to identify the top clone for each gene in the li-
brary. Only clones that mapped to consistent genomic coordinates based on sequencing of PCR
products adjacent to both ends of the insertion vector we considered. Then a Blast search was
used to determine which matches were statistically significant (E-value< 10-20), and to rule out
clones that mapped ambiguously to repetitive regions. Clones associated with a gene were re-
quired to disrupt at least 60% of the transcripts predicted for the gene, and to occur within the
first half of the coding region (exons) of the gene of interest. Clones having these criteria were
then ranked based on proximity of the insertion site to the start codon. We were able to identify
1614 unique clones in our library that both contained the β-galmarker inserted within the geno-
mic region of the endogenous gene and were cancer candidate genes. To further narrow the list
and enhance for novelty, we identified clones that represent genes that have been implicated in
DNA repair, apoptosis, and/or cell cycle, and do not already have extensively developed mouse
models based on data from the “Alleles and Phenotypes” tab in the Mouse Genome Informatics
database (http://www.informatics.jax.org/). Since these genes were specifically selected to not
have well-developed mouse models, they are relatively less known and studied than the more
Identification of Novel Targets for Radiation Response
PLOS ONE | DOI:10.1371/journal.pone.0120534 April 8, 2015 3 / 20
“classic” radiation response genes already identified in the literature. Ultimately, we identified
519 clones that were pulled from the library, thawed, expanded and assayed.
We utilized a number of different control clones for our assays on all plates within the course
of our experiments. Wild type (WT) ESCs were used as a control for the cell death and viability
assay. Changes in each clone’s viability due to radiation were normalized to the change in wild
type clone viability at the same radiation dose. Since wild type ESCs do not contain a β-gal insert,
they cannot be utilized for the evaluation of β-gal RLU; therefore, mutant ESC clones were used
for controls in our gene expression assays. To assess positive response (increased gene expression)
to radiation we utilized an ESC clone for Bbc3 (Puma) a well-known radiation response gene
[25]. Over the course of 22 separate experiments, we typically saw a mean 1.68 fold up-regulation
in expression at 4-Gy (SEM = 0.12). Sv2a, a gene involved in synaptic vesicle fusion, was used as a
negative control. Low-level expression of Sv2awas constant with or without irradiation.
Cell culture
Initial clone recovery was asynchronous; however, it was clear that recovery, expansion, and
synchronization was critical to simultaneous culture and subsequent assay performance. Un-
coupling expansion and testing ultimately allowed for a more high-throughput process. Select-
ed clones were thawed onto 24-well plates in ES media (DMEM, 15% FCS, 1× L-glutamate,
1×-Non-essential amino acids, 1×-nucleosides, 1×-Pen/Strep, 1×-2-Mercaptoethanol, 1mM so-
dium pyruvate, and 500U LIF). In order to maintain the undifferentiated state, clones were co-
cultured with MEFs as a feeder layer, passaged every other day and maintained in media con-
taining LIF. When cells were expanded and 85% confluent, they were frozen in quadruplicate.
Upon re-thaw, these clones were more efficiently recovered and synchronized by 2–3 passages
on MEFs followed by one passage on gel for subsequent use in assays.
Radiation exposure
Two different radiation absorbed doses were selected with which to screen. We chose 0.5-Gy as
a low clinically relevant absorbed dose, which is often also referred to as a hypersensitivity dose
[24] and 4-Gy, a dose that is higher than is normally delivered in clinical treatments. Thawed
cells were expanded and plated at forty thousand cells per well (96-well plate), cultured over-
night and then exposed to 0 (control), 0.5, and 4-Gy of ionizing radiation from a Theratronics
AECLT-780 Cobalt-60 Teletherapy unit at Texas A&M's College of Veterinary Medicine. A
SSD manual technique was used for treatment planning utilizing a correction-based algorithm
correcting back to calibration conditions. Briefly, the cell plates where set up 101 cm from the
source and entirely contained within a 30 × 30 cm open field. The prescription point was set to
target the dose to the top of the well. To ensure a homogeneous dose distribution across the en-
tire area of the field, the cell plates where encased in tissue equivalent material (1.0 cm above
and 0.5 cm below the plates) and the individual wells containing the cells within the plate were
filled to maximum capacity with support media. In addition, the plates were positioned at least
2 cm from the edge of the field to minimize any charge particle disequilibrium created at the
field edges. An ionization chamber positioned below the plate and an electrometer was used as
a secondary dose verification to ensure the delivered dose was within intended tolerance levels.
Twenty-four hours post-irradiation, cultures were harvested and assayed for differences in cell
viability and gene expression.
Cell death/viability assay
While clonogenicity assays remain the gold standard to evaluate radiosensitivity in vitro, they
are not amenable to high throughput screens. Hence, cell death/viability assays have been used
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in screens. For example, Sudo et al., 2007 [26] utilized the sulforhodamine B (SRB) assay to
evaluate cytotoxicity and survival fraction at 4 Gy after treatment of cells with RNAi in
HEK293 cells. Zheng et al., 2008 [27] used ATP monitoring to assess the cytocidal, cytostatic
and proliferative effects of 7.5 Gy radiation in glioblastoma cells after siRNA. Also, Choi et al.,
2011 [28] used the MTT assay to validate radiosensitivity induced by loss of ELAV4. We uti-
lized the Promega CytoTox-Glo Cytotoxicity Assay to determine cell death/viability after irra-
diation according to the manufacturer’s directions. This assay is a luminescent cytotoxicity
assay that measures the relative number of dead cells in cell populations by measuring the ex-
tracellular activity of a distinct intracellular protease when the protease is released from mem-
brane-compromised cells. The amount of luminescence directly correlates with the percentage
of cells undergoing cytotoxic stress. Further, a relative number of dead and living cells can be
calculated as well as a percent viability. The percent viability was calculated as the percentage
of viable cells divided by the total number of cells as
%viability ¼ viable cells
all cells
¼ all cells dead cells
all cells
 
:
We used wild type ESCs as a control for this assay and all data were normalized to wild type.
Gene expression assay
As the gene trap vector utilized to create our library contains beta-galas a reporter gene,its ac-
tivity can by assayed as a measure of endogenous gene expression of the trapped gene of inter-
est. Reporter genes such as β-gal are routinely utilized to evaluate gene expression. The
particular assay that we have employed is designed for rapid, sensitive, quantitative detection
of β-gal in cell lysates. The wide dynamic range of the assay measures enzyme levels accurately
from the femtogram to nanogram range. This assay has been previously validated, as it has
been utilized to evaluate radiation responsive gene expression in gene-trapped ESCs [23]. We
used the Applied Biosystem GalactoStar System according to the manufacturer’s directions to
quantify the relative amount of β-gal expression per living cells by taking the relative light units
of β-gal expression divided by the relative number of living cells as determined in the Cell
Death/Viability assay above. Importantly, even trapped genes induced rapidly after irradiation
would be expected to lead to increased β-gal activity at 24 h because β-gal is a stable protein.
QC
After the initial round of testing we selected 18 genes/clones of interest. These clones were sub-
jected to a rigorous QC analysis. Genomic sequencing was used to verify the exact insertion
site of the vector within the gene of interest and Q-PCR verified the presence of one copy of the
neomycin gene per genome to ensure single inserts. We also tested for presence of the Sry gene
as a marker for the retention of the Y-chromosome in the cell line, and for contaminants such
as mycoplasma and mold.
Hit validation
We next wanted to validate radiation responsiveness in clones that passed QC by utilizing both
time-course and dose-response studies for both gene expression and cell death/viability assays.
For time-course experiments, cells were exposed to 4-Gy of radiation at 0, 6, 24, and 48 hours
before being harvested for the assays. For dose-dependence experiments, cells were irradiated
with doses of 0.5, 2, 4, 10 and 15-Gy and harvested 24 hours later.
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q-RT-PCR
RNA was extracted from cells using Qiagen RNeasy Mini kit, catalog number 74106 and quan-
titated by Nanodrop fluorimeter. We utilized QuantiTect SYBR Green RT-PCR Master Mix
(Mat. number 1026225) to perform RT and PCR on the same reaction. QuantiTect Primer
Assay gene specific primers for Gapdh, Vcan, Brca2, H3f3a, and Klf8 were used on a Stratagene
Mx3005P System that ran the following cycling parameters: Reverse transcription for 30 min
50°C; PCR initial activation 15 min 95°C; followed by 40 cycles of Denaturation 15 sec 94°C,
Annealing 30 sec 55°C, and extension 30 sec 72°C. Each RNA sample was amplified in tripli-
cate and cycle thresholds (Ct) were determined automatically and delta Ct for each cell line
were determined by subtracting the gene of interest Ct from the Gapdh Ct. Differences in delta
Ct were determined between unirradiated and irradiated clones.
RTCA analysis
Real Time Cell Analysis (RTCA) was performed using an ACEA Biosciences Inc., xCELLigence
RTCA DP system on the six validated clones. The collected data detail the response of the mu-
tant cells and wild type murine ESC for both 2-Gy and sham irradiations for a period of 120
hours post irradiation. The wells used for the mutant and controls were seeded with 10,000
cells each. Cell populations were measured as a function of time after irradiation to assess radi-
ation effects on cell survival and cell index. Cell index was normalized at the time of
radiation exposure.
Results
Identification of mutant clones for assays
We identified and selected 519 mutant clones that represent genes that have been implicated in
DNA repair, apoptosis, and/or cell cycle. “Classic” radiation response genes, such as p53, were
intentionally avoided so that we could identify novel genes. Clones were pulled from the li-
brary, thawed, expanded and assayed. Data on 386 mutant clones are presented in S1 Table for
both assays at 0.5 and 4-Gy. As each assay was done in duplicate, data are given for the average
of the duplicates for change in % viability and the average log ratio of β-gal activity normalized
to the number of live cells determined by the Cyto-Tox Glo assay. Further, we calculated corre-
lation scores between the duplicates for each experiment. The correlation score for the Cyto-
Tox Glo assay is 0.72 and the β-gal assays is 0.98 indicating that our data are robust.
Identification of genes associated with changes in viability after
irradiation
We selected three genes (Brca2, Cdc25a, and Rpa1) to both validate the Cyto-Tox Glo assay
and allow for cross-platform comparison. Based on reports in the literature, we demonstrate
the anticipated phenotypes in our mutant ESCs (S1a Fig.). Depletion of BRCA2 by siRNA
leads to cells that were able to overcome the normal G2 arrest after irradiation of U2OS cells at
6 Gy [29]. Hence, we see an increase in viability by up to 5% in ESCs. Cdc25a is well studied for
its role in cell cycle check point regulation; it is required for progression from S to G2 phase
[30]. When cells are exposed to radiation, Cdc25a is degraded and the cell cycle is arrested.
Hence, loss of Cdc25a results in delay of cell-cycle progression such that cells can repair the
damage. As a result, we observed increases in viability 24 hours after irradiation by 5%. We
also observed decreased viability in ESCs with mutant Rpa1 by over 8%. Previous studies have
shown that siRNA to Rpa1 results in increased radiosensitivity as measured by decreased
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survival fraction and halted cell cycle progression at G2/M phase [31]. Note that by compari-
son, the wild type clone has a loss of viability of less than 3% even at 4 Gy.
During screening, we did not observe large differences in radiation induced cell death based
on genotype, possibly due to the inherent radiation resistance of stem cells (Fig. 1). However, we
did observe moderate changes in live cell numbers and % viability (Fig. 1) due to radiation
(paired t-test of difference in % viability over all clones, 0-Gy vs 4-Gy, p< 0.00001). Such results
can be explained by an arrest in cell growth induced by radiation. Mean viability (μwt) for wild
type cells was around 0.6 for all treatment conditions (0-Gy, 0.5-Gy, and 4-Gy). Changes in via-
bility (ΔV) from 0.5 and 4-Gy to 0-Gy (i.e., ΔV = V4Gy—V0Gy) Δ viability = % viability4Gy—
% viability0Gy), were calculated for all clones as well as for 22 wild-type replicate samples. To
identify genes associated with changes in viability, Z-scores were calculated for all clones relative
to the wild type as
z ¼ DVmwt
swt
where μ = mean and σ = standard deviation. Thus, wild type samples represent the variability
expected due to chance, and those clones that significantly deviate from this distribution are
likely to be associated with a response to radiation. In fact, a histogram of the Z-scores shows a
standard Normal distribution (black line in S1b Fig.). To assess significance, p-values were cal-
culated based on a two-tailed distribution of Z-scores. Using a p-value cut-off p< 0.01, we iden-
tified a total of 28 unique genes associated with significant changes in viability: 5 associated with
decreased viability at 0.5-Gy, 16 associated with increased viability at 0.5-Gy, and 7 associated
Fig 1. Cytotoxicity assay performance. Estimate of Dead cell relative light units (RLU), Live cell RLU, and
% Viability for all clones at 0-Gy, 0.5-Gy and 4-Gy irradiation. While dead cell RLUs do not show statistically
significant changes, changes in live cell RLUs and% Viability at 4-Gy are statistically significant indicating
that as a whole, clones show fewer live cells and decreased viability at 4-Gy, presumably due to cell cycle
arrest and decreased cell division.
doi:10.1371/journal.pone.0120534.g001
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with increased viability at 4-Gy (Table 1). Of the 5 clones that exhibited a decrease in viability at
0.5-Gy, two are associated with a response to oxidative stress:Nuclear respiratory factor 1 (Nrf1)
and Peroredoxin 3 (Prdx3). Of those that exhibited an increase in viability at 0.5-Gy, several are
involved in controlling the cell cycle:Minichromosome maintenance complex component 2
(Mcm2), CASP2 and RIPK1 domain containing adaptor with death domain (Cradd) and retino-
blastoma binding protein 5 (Rbbp5). At 4-Gy, no genes were statistically significantly associated
with loss of viability, but among the 7 genes associated with increased viability, 2 are cell-cycle
proteins such as cell division cycle 25c (Cdc25c) and Ras-related protein Rab-8a (Rab8a).
Identification of genes associated with changes in gene expression after
irradiation
To quantify the relative amount of the trapped gene’s expression we utilized the β-gal construct
incorporated into the trapping vector and determined the relative light units of β-gal expres-
sion per well and divided by the relative number of living cells as determined in the Cell Death/
Viability assay. We then determined the ratio of RLU at 0.5-Gy to 0-Gy and 4-Gy to 0-Gy and
compared each clones value to itself at the various radiation doses. For plotting in graphs, these
ratios were then converted to log scale and Z-scores were calculated by estimating the mean
Table 1. Genes associated with significant changes in viability.
Gene Change % Viability Z-Score p-value
Decreased Viability Hits 0-Gy vs 0.5-Gy Prdx3 -30.89% -4.41953 9.89E-06
Bcap31 -30.51% -4.36329 1.28E-05
Bach1 -22.49% -3.15661 0.001596
Nrf1 -22.37% -3.13909 0.001695
Vamp12 -22.07% -3.09443 0.001972
Increased Viability Hits 0-Gy vs 0.5-Gy Mcm2 25.78% 4.100149 4.13E-05
Cradd 24.46% 3.901591 9.56E-05
Rbbp5 22.74% 3.643607 0.000269
Lims1 22.58% 3.619399 0.000295
Ctnna1 19.96% 3.224992 0.00126
Arl6ip5 19.87% 3.212631 0.001315
Dpagt1 19.55% 3.164071 0.001556
Rfx2 19.28% 3.123158 0.001789
Thrap3 18.98% 3.078622 0.00208
Casc3 18.37% 2.98651 0.002822
Ttl 18.36% 2.985033 0.002835
Nrip1 17.72% 2.88807 0.003876
Mll3 17.69% 2.883578 0.003932
Psmb10 16.18% 2.65656 0.007894
Topors 15.87% 2.611167 0.009023
Exo1 15.68% 2.581592 0.009835
O-Gy vs 4-Gy Cdc25c 39.77% 5.313806 1.07E-07
Rab8a 36.36% 4.887382 1.02E-06
Bclaf1 29.79% 4.065455 4.79E-05
Bcl7a 23.51% 3.280737 0.001035
Kif22 19.35% 2.760707 0.005768
Cux1 19.16% 2.736151 0.006216
Scpep1 17.91% 2.58025 0.009873
doi:10.1371/journal.pone.0120534.t001
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and standard deviation with the clones themselves. We used the robust RANSAC algorithm to
help remove the impact of outliers on parameter estimates [32]. Significant hits are defined as
those with p<0.01 and are detailed in Table 2 for each radiation dose. In total we identified 20
genes with significantly altered expression; 13 with decreased expression and 7 with increased
expression. Only 3 genes are identified as significantly altered in both radiation doses: BRCA1/
BRCA2-containing complex, subunit 3 (Brcc3), Peroxisomal biogenesis factor 14 (Pex14), and
Destrin (Dstn).
GO term analysis
Analysis of GO term enrichment among significant hits reveals similarity in gene functions.
Hits for increased and decreased viability and increased and decreased expression were evaluat-
ed separately. Hits for 0.5-Gy and 4-Gy were pooled in each of the four categories. The compar-
ison takes the hits as input, and compares them against the 386 genes in the screen as a
background set to see if there is over-representation of any GO term. Enrichment was further
refined by making sure that there were at least 3 genes in the starting population set for each
GO term and 2 hit genes represented for each GO term. Table 3 details the enriched GO terms
and associated genes. It is not surprising that genes necessary for “mitochondrial organization”
and antioxidant response (Nrf1 and Prdx3) might be required for cell survival after radiation
stress. It also makes sense that genes involved in microtubule anchoring (Pex14) and actin de-
polymerization (Dstn) might be upregulated so the cell could arrest division to repair; or that
Table 2. Genes associated with significant changes in gene expression.
Gene Log Ratio β-Gal Z-Score p-value
Decreased Expression Hits 0-Gy vs 0.5-Gy Brcc3 -1.77153 -12.4129 0
Grb7 -0.62621 -4.24135 2.22E-05
Nap1l4 -0.51406 -3.44121 0.000579
Cep68 -0.51189 -3.42576 0.000613
Anapc7 -0.50525 -3.37836 0.000729
Rfx2 -0.45217 -2.99962 0.002703
Rhbdd3 -0.40548 -2.66652 0.007664
O-Gy vs 4-Gy Brcc3 -1.85002 -9.34039 0
Ing4 -0.92325 -4.48835 7.18E-06
Epc1 -0.89975 -4.36531 1.27E-05
Mtap4 -0.89935 -4.3632 1.28E-05
Atp2b1 -0.63371 -2.97248 0.002954
Adnp2 -0.60024 -2.79726 0.005154
Diablo -0.59001 -2.74367 0.006076
Increased Expression Hits O-Gy vs 4-Gy Serinc3 1.180251 6.524403 6.83E-11
Pex14 0.739167 4.21514 2.5E-05
Dstn 0.468382 2.797459 0.005151
0-Gy vs 0.5-Gy Dstn 0.441173 3.374142 0.00074
Pex14 0.383902 2.965529 0.003022
Ptbp2 0.368237 2.853763 0.00432
Prdx3 0.357476 2.776985 0.005487
Ccnb1 0.351157 2.731898 0.006297
Tnfaip8 0.345919 2.69453 0.007049
doi:10.1371/journal.pone.0120534.t002
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genes involved in suppressing apoptosis (Prdx3 and Tumor necrosis factor, alpha-induced 8,
Tnaip8) might be upregulated. Further, genes that regulate growth are plausibly down regulat-
ed. However, there is no obvious link between genes that increased viability and involvement
in Golgi vesicle transport, and links between down regulating genes involved in the plasma
membrane or the ubiquitin ligase complex are also unclear.
Validation—Clone selection and QC analysis
From the original 386 clones, we selected 18 for further validation. Details on selected clones
are shown in Table 4, which lists gene symbols, names, functions, their scores in the first round
of assays, and the reason they were selected for further screening. Clones were selected based
on one of five criteria: increases in % viability (IQ motif containing GTPase activating protein
(Iqgap1), UDP-N-acetylglucosamine—dolichyl-phosphate N-acetylglucosaminephosphotransfer-
ase (Dpagt1), BCL2-associated transcription factor 1 (Bclaf1), Cell division cycle 25 c (Cdc25c),
and Kinesin family member 22 (Kif22)); decreases in % viability (BTB and CNC homology 1
(Bach1), Dynein light chain roadblock-type 1 (Dynlrb1),Mitogen-activated protein kinase kinase
6 (Map2k6),Wings apart-like homolog (Wapal), and heterogeneous nuclear ribonucleoprotein
A3 (Hnrnpa3)); gene up-regulation in response to radiation (Versican (Vcan) and Destrin
(Dstn)); gene down-regulation in response to radiation (Inhibitor of growth family,member 4
(Ing4) and RNA binding protein with multiple splicing (Rbpms)); and simultaneous changes in
both % viability and in gene expression (G1 to S phase transition 1 (Gspt1), cut-like homeobox 1
(Cux1), Krueppel-like factor 8 (Klf8), and ATPase, Ca++ transporting, plasma membrane 1
(Atp2b1)). Of these 18 clones, only Bach1, Dpagt1, Cdc25, Bclaf1, Cux1, Ing4, Atp2b1, and Dstn
had p- values< 0.01 and represent the more extreme phenotypes. Ten clones were selected
based on moderate phenotypes. Additionally, some of these genes are involved in similar pro-
cesses. For example, several are related to the cytoskeleton; Dstn is an actin depolymerizing fac-
tor and both Dynlrb and Kif22 are involved in microtubule based movement. Several others are
involved in cell cycle regulation and division: Cdc25c, Bach1, andWapal.
Table 3. Evaluation of hits for GO enrichment.
Phenotype GO number GO term Genes Total in
population
Q-
value
Increased Viability GO:0044431 Golgi apparatus part Cux1, Rab8a 8 0.0101
Increased Viability GO:0048193 Golgi vesicle transport Cux1, Rab8a 8 0.0325
Decreased Viability GO:0007005 mitochondrion organization Nrf1 and Prdx3 6 0.0021
Increased
Expression
GO:0022411 cellular component disassembly Dstn, Pex14 18 0.0053
Increased
Expression
GO:0009607 response to biotic stimulus Prdx3, Tnfaip8 11 0.0084
Increased
Expression
GO:0043154 negative regulation of cysteine-type endopeptidase activity involved
in apoptotic process
Prdx3, Tnfaip8 5 0.0084
Decreased
Expression
GO:0000123 histone acetyltransferase complex Epc1, Ing4 4 0.0081
Decreased
Expression
GO:0005887 integral component of plasma membrane Atp2b1, Diablo 6 0.0184
Decreased
Expression
GO:0040008 regulation of growth Adnp2, Epc1,
Ing4
22 0.02
Decreased
Expression
GO:0000152 nuclear ubiquitin ligase complex Anapc7, Brcc3 7 0.0208
doi:10.1371/journal.pone.0120534.t003
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Table 4. Selected radiation response genes.
0.5 Gy 4 Gy
Symbol Name Function Delta %
Viability
B-Gal
Fold
Change
Delta %
Viability
B-Gal
Fold
Change
Reason
Selected
Iqgap1 IQ motif containing
GTPase activating
protein 1
IQGAP may regulate cell morphology; C-
terminal domain of IQGAP inhibited the
GTPase activity of cdc42
7.67 -1.48 -2.19 -1.58 Increased
Viability
Dpagt1 Dolichol phosphate
GlcNAc-1-phosphate
transferase
GlcNAc-1-P transferase, target of Wnt/
beta-catenin signaling pathway
19.55 -2.01 7.06 -1.78 Increased
Viability
Bclaf1 BCL2-associated
transcription factor 1
induction of apoptosis, negative regulation
of transcription, DNA-dependent, a
transcriptional repressor that interacts with
BCL2-related proteins
6.93 -1.29 29.79 -1.70 Increased
Viability
Cdc25c cell division cycle 25C cell cycle, cell division, phosphoprotein
phosphatase activity
9.40 1.19 39.77 -1.39 Increased
Viability
Kif22 kinesin family member
22
DNA repair, microtubule-based movement;
may play a role in regulating the
movement of chromosomes along
microtubules during mitosis
14.46 -1.02 19.35 -1.60 Increased
Viability
Bach1 BTB and CNC
homology 1
negative regulation of transcription from
RNA polymerase II promoter
-22.49 1.35 -21.38 1.34 Decreased
Viability
Dynlrb1 dynein light chain
roadblock-type 1
microtubule-based movement, transport -15.96 -1.13 -20.32 1.57 Decreased
Viability
Map2k6 mitogen-activated
protein kinase kinase 6
Serine/threonine-protein kinase 3.51 1.69 -10.32 2.18 Decreased
Viability
Wapal wings apart-like
homolog (Drosophila)
cell cycle, cell division; oncogene,
malfunction of the WAPL pathway may
activate an S phase checkpoint or other
apoptotic pathway leading to cell death
5.47 -1.16 -12.55 1.13 Decreased
viability
Hnrnpa3 heterogeneous nuclear
ribonucleoprotein A3
mRNA transport -15.45 1.25 -18.12 1.16 Decreased
viability
Vcan Versican A proteoglycan, interferes with CD44/ErbB-
dependant signaling; specifically interacts
with hyaluronan
-2.98 1.21 -3.92 2.30 Increased
Expression
Dstn Destrin actin depolymerizing factor 6.00 2.76 -6.00 2.94 Increased
Expression
Ing4 Inhibitor of growth
familiy member 4
tumor suppressor, apoptotic process, cell
cycle; regulates brain tumour angiogenesis
through transcriptional repression of NF-
kappaB-responsive genes
-1.00 -1.10 -8.00 -8.38 Decreased
Expression
Rbpms RNA binding protein
with multiple splicing
RNA-binding protein: marker for retinal
ganglion cells; positive regulation of
pathway-restricted SMAD protein
phosphorylation
12.39 -1.52 -0.38 -2.31 Decreased
Expression
Gspt1 G1 to S phase transition
1
involved in translation termination -5.57 -1.48 9.61 -3.61 Increased
Viability;
Decreased
Expression
Cux1 cut-like homeobox 1 intra-Golgi vesicle-mediated transport 2.12 1.08 19.16 -2.46 Increased
Viability;
Decreased
Expression
Klf8 Kruppel-like factor 8 promotes tumor invasion 5.29 1.00 13.34 -3.08 Increased
Viability;
Decreased
Expression
(Continued)
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Clones of interest were subjected to QC assays where we verified the exact insertion site of
the mutagenic gene trap and confirmed that they had a single insertion. Then they were pro-
gressed to further secondary assays. The subsequent data for each clone is summarized in
S2 Table. For time course experiments, ESCs were exposed to 4-Gy irradiations at 4, 6, 24, and
48 hours before being harvested for the assays. The 48 hour time point shows the greatest
range in change in % viability and extends from-6% to + 14% for Cdc25c and Dpagt1 respec-
tively (Fig. 2a).Map2k6 and Iqgap also show increased viability (12.7 and 8.1% respectively) at
48 hours. In terms of gene expression, the 48 hour time point also has the most range primarily
due to Vcan with a 2.76 fold increase (log (2.76) = 0.44) (Fig. 2b). Otherwise, the other time
points do not provide much range in terms of dramatically altered gene expression.
For dose-dependence experiments, cells were irradiated with doses of 0, 0.5, 2, 4, 10 and
15-Gy and harvested 24 h later. As expected, when we assessed changes in % viability the most
noticeable result is that as radiation doses increase, cell viability decreases (Fig. 2c). In fact, all
clones saw a drop in % viability at 4 and 10-Gy, though at 15-Gy Cdc25c saw an increase in via-
bility of 7%. We see the most range in changes in % viability at the lower doses of radiation
(0.5-Gy and 2-Gy where we see changes +/- 11%). At low doses of radiation, both Klf8 and
Cdc25c clones show increases of 12 and 8% viability respectively. While this data seems contra-
dictory with the above observation of Cdc25c having decreased viability, it is important to note
that at 4-Gy, Cdc25c has decreased viability. Again, this is consistent with time course data.
Evaluation of gene expression indicates that at high levels of radiation, gene expression is re-
duced (Fig. 2d). Ing4 and Klf8 are reduced by as much as 3 and 2.5 fold at 15-Gy. At 4-Gy, gene
expression is not changed by more than 2 fold for any of the clones. In general Ing4, Rbpms,
and Klf8 show decreased gene expression with radiation, while Vcan consistently shows in-
creased gene expression except at the very high dose of 15-Gy. Dstn shows increases at low
dose radiation and decreases at high dose radiation. Further, we see that 2-Gy provides the
most dynamic range for changes in gene expression (from 2 fold decreases to 3 fold increases).
These data stress that changes in gene expression are sensitive to the dose of radiation.
In general, our secondary assays were able to confirm 13 clones we had identified as having
altered responses to radiation in the first round of assays did in fact test positive in a repeat
test. These genes included: Iqgap, Dpagt1, Klf8, Cdc25c, Bach1, Dynlrb1,Map2k6, Vcan, Dstn,
Ing4, Rbpms,Wapal, and Hnrnpa3. Five of these had been identified as having statistically sig-
nificant changes (Dpagt1, Cdc25c, Bach1, Dstn, and Ing4).
We have further validated expression of some radiation response genes and a few of our hits
by q-RT PCR in wild type (WT) ESCs after radiation. We chose to utilize WT ESCs to show
that the trapping construct wasn’t introducing any artifacts into the mutant cells. We utilized
Table 4. (Continued)
0.5 Gy 4 Gy
Symbol Name Function Delta %
Viability
B-Gal
Fold
Change
Delta %
Viability
B-Gal
Fold
Change
Reason
Selected
Atp2b1 ATPase, Ca+
+ transporting, plasma
membrane 1
ATP binding, hydrolase activity, Calcium
ion transport
13.90 -1.39 14.00 -4.30 Increased
Viability;
Decreased
Expression
doi:10.1371/journal.pone.0120534.t004
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Gapdh for normalization (calculation of dCt) as has been done by several other manuscripts
that utilize q-RT PCR to detect changes in gene expression due to radiation [33,34]. We then
compared unirradiated and irradiated samples (to calculate ddCt) to determine changes in
gene expression. Again, we see the expected changes in expression. We evaluated Vcan by q-
RT PCR and see increases in expression of over 4 fold at 4 Gy (S2 Fig.). Our previous data from
the β-gal assay suggested changes of over 2 fold (Fig. 2d). The literature also confirms this find-
ing as Vcan is consistently upregulated both in our studies and in the literature [35]. BRCA2
has been shown to decrease in expression after irradiation [36]. We see expression at 4 Gy drop
to 0.73 fold the level observed without radiation by q-RT PCR (S2 Fig.). Data from the β-gal
assay suggested decreased expression by almost 3 fold (data not shown). H3F3A has been
shown to increase expression after radiation [37]. Accordingly, we see increases of up to 1.22
fold at 4 Gy by q-RT PCR (S2 Fig.) and1.5 fold by β-gal (data not shown). We also evaluated
Klf8 expression by q-RT PCR and we see expression at 2 Gy drop to 0.77 fold the level observed
without radiation by q-RT PCR. This was also observed by β-gal expression dropping approxi-
mately 2 fold (Fig. 2d). Hence, we see correlation in changes in gene expression between q-RT
PCR and β-gal.
RTCA analysis
Seven of the validated mutant clones were selected for further analysis. Cell growth studies
were carried out using a Real Time Cell Analyzer (RTCA, ACEA Biosciences, Inc., California)
to assess their radiation response as a function of time. The power inherent in this particular
assay is it allows us to follow the cell index (CI) continuously over several days such that we are
allowed a more complete overview than the previous time course assay where we only were
able to obtain 4 discreet time points. The results are presented in Fig. 3 and show the cell
Fig 2. Validation assays. (A) Change in % viability over time for selected clones. (B) Change in gene expression over time for selected clones. (C) Change
in % viability due to radiation dose for selected clones. (D) Change in gene expression due to radiation dose for selected clones. Error bars indicate SEM.
doi:10.1371/journal.pone.0120534.g002
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growth as a function of time after irradiation at 2 and 0-Gy (control/sham) for a period of 120
hours. The data indicate that gene traps even without radiation exposure result in changes in
both the maximum CI and the time in which it is achieved. For example, WT cells achieve a
maximum CI of 2 within 40 hours and then declined to a CI of approximately 0.5 at 100 hours.
Map2k6 clones only reach a CI of 1.5 and take about 20 hours to achieve. However, Vcan
reached a CI of 3.5 within 48 hours. Irradiated WT ESCs became arrested with no significant
change in cell population (CI ~ 1) as a function of time. The irradiated mutants behave differ-
ently and such data can be utilized to predict how using a therapeutic drug to inhibit these
genes would result in increased (or decreased) response to radiation therapy. For example, we
have 2 targets that when knocked down show enhanced sensitivity to 2-Gy radiation (in com-
parison to WT). Dstn is the best target. Dstn has a lower CI than WT even w/o radiation. ES
cells with this gene trap show CI that do not recover after irradiation and our other assays
(time and dose response) support this finding as we saw a change in viability of-10% at 2-Gy in
our dose response assays and-7% at 4-Gy after 24 hour (S2 Table).Map2k6 also shows en-
hanced sensitivity to 2-Gy over time. The RTCA data is further supported by our dose response
data showing a change of-10% viability at 2-Gy. Further, we have identified clones that show
enhanced resistance to radiation. Iqgap and Vcan clones both have cell indexes higher than
WT and when exposed to radiation, the clones initially show a slight decrease in CI, but then
the CI rebounds to a level even higher than the unirradiated WT clones. This rebound occurs
Fig 3. Cell growth as a function of time for wild type (WT) and (A) Dpagt1-mutant ESCs, (B) Klf8-mutant ESCs, (C) Dstn-mutant ESCs, (D)
Iqgap1-mutant ESCs, (E) Map2k6-mutant ESCs, (F) Vcan-mutant ESCs, (G) Rbpms-mutant ESCs. Cells were irradiated with a dose of 2-Gy just before
incubation using x-rays. Error bars indicate SEM.
doi:10.1371/journal.pone.0120534.g003
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at a late time point, past 48 hours which was the last time point we checked in the secondary as-
says. Vcan clones show significant resistance to radiation as the CI persists over 2 at 120 hours.
Discussion
Performance of the Screen
In order to define genes that both increase and decrease radiation sensitivity, we evaluated the
ability to use a library of gene-trapped murine ESCs for identification of gene function and
demonstrated that we were able to identify reproducible phenotypes. Eighteen clones were se-
lected, 10 with rather moderate phenotypes, for additional studies. Of these, 13 repeated the
phenotype of interest, a good indication that initial hits are not false positives. Further, of these
13 clones we have validated, 7 have been described in the literature as being involved in radia-
tion response, this further indicates that our screen performs well. Consistent with our find-
ings, Cdc25c repression prior to low-dose radiation induced more distinct hyper-
radiosensitivity and prevented the development of induced radioresistance [38]. Literature on
Bach1 indicates that inhibition of the protein protects against UVA induced damage [32], but
does not necessarily indicate if that occurs through cell cycle arrest and apparent decreases in
% viability as we have observed. Also consistent with our data, literature indicates that gamma
irradiation leads to the activation ofMap2k6, a cell cycle regulator that alters % viability as we
have observed [39]. Dstn is reported to have decreased expression upon UV exposure [40].
While our studies show an increase in expression at low radiation doses, higher doses show de-
creased expression. This apparent discrepancy could be due to the different types of radiation,
the different cell lines utilized, the total absorbed dose of radiation, or the time point after
which the expression was assayed. Vcan consistently is upregulated both in our studies and in
the literature [35]. Ing4 was selected due to changes in expression, while the literature indicates
that over-expression of Ing4 increases radiosensitivity [41]. Finally, Rbpms is reported to be
down-regulated in radiation-damaged cells which we also observed [42].
In comparison to other screening platforms, the most similar platform involves evaluating
siRNA libraries for their effect on radiation response. There have been several small studies
evaluating the effects of several hundred siRNAs per study on radiation response. One study
targeted the human kinome with siRNA and while they identified BRCA2 as a key regulator of
G2 checkpoint maintenance, they also noted that several kinases with known checkpoint roles
were not identified [29]. The authors suggest that this is a reflection of the lack of siRNA-
knockdown efficacy. Another study targeted genes involved in DNA damage repair by siRNA
and also determined that loss of BRCA2 resulted in increased DNA damage in SQ20B cells
after irradiation with 4 Gy [34]. In comparison, we find that loss of Brca2 in ESCs results in in-
creased cell viability and decreased Brca2 expression. A third study evaluated siRNAs for 200
genes and response to 4 Gy by assaying cell survival with SRB [26] and found loss of genes
such as H3F3A and ZDHHC8 had decreased viability. We also tested ESCs with targeted
H3f3a and Zdhhc8 mutations for changes in viability. While we see decreased viability for each
clone, the observed changes of 1.6% and 3.2% viability are rather modest and may reflect the
fact that the ESCs contain heterozygous mutations (data not shown). Hence, while siRNA
screens may have false negatives due to inefficient knockdown; comparatively, mutant ESC
screens may have a more stringent threshold for activity and may not identify targets where
low levels of activity are sufficient for response. However, our data indicate that ESC screens do
identify genes where heterozygous loss leads to a more robust phenotype.
It is important to note that evaluation of siRNA libraries precludes simultaneous evaluation
of specific targets for radiation induced changes in gene expression as we have done in our
screen. Alternative platforms for evaluation of gene expression changes include microarray
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and RNA-Seq analysis. Generally speaking, RNA Seq data are extremely accurate with a false
positive rate of< 2% [43]. And q-RT PCR results agree more closely with Illumina sequencing
results than with microarrays [44]. We were able to see changes in H3f3a expression based on
β-gal and q-RT PCR; it was identified in the literature through microarray [37]. Hence, while it
is possible to anticipate that different results could occur due to the inherent difference between
evaluation of mRNA levels verses evaluation of the stable β-gal enzyme; β-gal expression in
mutant ESCs provides a reasonable assay to evaluate a specific gene’s expression in a high
throughput manner.
Importance of time and dose
The findings in our own secondary assays strongly support the importance of both dose and
time dependence. For example, Cdc25c shows dramatic changes in viability based on absorbed
dose (Fig. 2c). The RTCA assays follow individual clones over time and show that for genes
such as Vcan and Iqgap, the short-term arrest that might look promising, is followed by a re-
bound that indicates radiation resistance. Both of these factors are likely to have significant
clinical relevance and indicate that any genes identified in such screens must be carefully stud-
ied and put into a more clinical context.
In terms of screening, it also appears that evaluation of radiation effects at 24 hours is suffi-
cient to identify genes of interest. The time course assays revealed that generally speaking we see
changes in gene expression within 6 hours and while this tends to peak by 48 hours, evaluation
at 24 hours is sufficient. Dose response assays indicate that utilization of 2-Gy yields the largest
range. Further, 2-Gy is a clinically relevant dose which spans the threshold between inducing
the most damage without activating the maximum amount of repair processes. Dose response
assays also indicate that doses above 10-Gy are rather ineffective if the main goal is only induc-
ing chromosomal aberrations that cannot be repaired and ultimately lead to the death or senes-
cence. This analysis is reinforced both by our data, with doses of radiation up to 15-Gy where
we were unable to detect any significant increases in cell death, and by numerous other studies
that found high dose irradiation was no more effective than low dose irradiations [45–48].
New radiation response genes identified
Our data indicate that the following 13 genes are involved in radiation response: Iqgap, Dpagt1,
Klf8, Cdc25c, Bach1, Dynlrb1,Map2k6, Vcan, Dstn, Ing4, Rbpms,Wapal, andHnrnpa3
(Table 3). Half of these (Cdc25c[38], Bach1[32],Map2k6[39], Dstn[40], Vcan[35], Ing4[41],
and Rbpms[42]) have been previously implicated in radiation response while the others (Iqgap,
Dpagt1, Klf8, Dynlrb1,Wapal, andHnrnpa3) have never been implicated in radiation response.
These new genes will require additional study.
Of particular interest is the transcriptional repressor Klf8 [49]. Over-expression of KLF8 has
been associated with a number of different cancer types including: ovarian carcinoma, renal
cell carcinoma, hepatocellular carcinoma, breast cancer, gliomas, and gastric cancer [50–57].
KLF8 induces epithelial-mesenchymal transition (EMT), a hallmark of cancer invasion and
metastasis. Further, KLF8 has been implicated in DNA-repair and is a factor contributing to
therapeutic resistance [58]. It is reasoned that KLF8 could play a role in altering genomic integ-
rity through aberrant DNA repair function and therefore contributing to the aggressive pro-
gression of cancer. Interestingly, its homolog, KLF4 prevents ESC differentiation and is
important for the maintenance of self-renewal and pluripotency. Experimental evidence sug-
gests that it could be therapeutically beneficial to patients undergoing radiation therapy to also
receive a therapy that targets KLF8 activity. This is especially true considering a paper by Wang
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that demonstrated KLF8’s ability to promote human breast cancer cell invasion and metastasis
by transcriptional activation of MMP9 [59].
It is important to note that even though we have utilized two separate phenotypes for
screening (cell viability and gene expression) this does not imply that we have identified all
types of radiation response genes. For example, induction of DNA damage response more
often does not rely on induction of protein expression, but rather on posttranslational modifi-
cations, including phosphorylation, ubiquitinylation, etc. Hence, unless such genes have a di-
rect effect on cell viability, the expression based screen that we utilized would not be able to
identify them.
Using mutant murine ESCs has at least three additional advantages as well. First, given the
similarities to cancer stem cells, they provide excellent models for determining gene function
in cancer stem cells. Unfortunately, it is unknown how the genes we have identified function
specifically in cancer stem cells and what role if any they might play in the maintenance of
stemness or differentiation. Evaluation of these genes’ expression and function in populations
of cancer stem cells would provide valuable information as to their utility as therapeutic targets.
Unfortunately, acquisition of such cell populations is extremely difficult and outside the realm
of this particular study. Second, power lies within the fact that ESCs can be differentiated. Once
a gene is identified; specific clones can be utilized for differentiation immediately and evaluated
in multiple cell types in vitro. Alternatively, a library of clones can be differentiated simulta-
neously in parallel and each clone screened individually. Finally, these ES cells can be used to
generate mutant (knock out) mice. Three of the genes we identified do not currently have
mouse models: (Dynlrb1, Rbpms, and Hnrnpa3). Also, none of the mouse models that do exist
have been evaluated for radiation response. It is important to note that some of these null mice
are embryonic lethal; however, heterozygous mice could be evaluated for phenotypes in re-
sponse to radiation.
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S1 Fig. a) Change in % viability due to radiation dose for selected clones. Error bars indicate
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